Related Experiment Videos
[The complications of manual therapy in osteochondrosis of the cervical spine]
Likars'Ka Sprava
|October 1, 1992
Abstract:
The authors analyze literary and own findings on complications of manual therapy. The causes and clinical picture of possible complications are discussed. An original classification of complications due to manual therapy of cervical spine disorders is presented.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
[Phenomenon of anticipation in a patient with dystrophic myotonia type 1].
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2025
[Adult leukoencephalopathy with axonal spheroids and pigmented glia].
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2025
[Breathing disorders during sleep in patients with dystrophic myotonia].
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2024
[Dolichoectasia of the basilar artery caused by cystic medial degeneration, as a cause of neurovascular conflict with damage to the trigeminal, facial and vestibulocochlear nerves].
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2023
[Non-invasive ventilation of the lungs in neuromuscular diseases].
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2021
[Alternating hemiplegia].
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2020
[CHANGES IN THE METABOLISM IN THE MYOCARDIUM OF RATS WITH ARTERIAL HYPERTENSION].
Likars'ka sprava·2016
Time to Treatment Failure as a Recorded Treatment-Process Measure in C-CAT. Reply to Comment on "Facility-Level Medical Oncology Specialist Availability and First-Line Time to Treatment Failure in Lung Cancer: A Nationwide C-CAT Registry Analysis. Curr. Oncol. 2026, 33, 462".
Current oncology (Toronto, Ont.)·2026
Does Time to Treatment Failure Measure the Same Clinical Process Across Oncology Facilities? Comment on Kajiura et al. Facility-Level Medical Oncology Specialist Availability and First-Line Time to Treatment Failure in Lung Cancer: A Nationwide C-CAT Registry Analysis. Curr. Oncol. 2026, 33, 462.
Current oncology (Toronto, Ont.)·2026
[177Lu]Lu-PSMA-617 in Metastatic Hormone-Sensitive Prostate Cancer: Evidence from PSMAddition and Considerations for Treatment Sequencing.
Current oncology (Toronto, Ont.)·2026
A New Era of Treatment Sequencing in Platinum-Resistant Ovarian Cancer: Integrating Immunotherapy, Antibody-Drug Conjugates, and Targeted Therapies.
Current oncology (Toronto, Ont.)·2026